Maho Yamashita Selected Research

Proteins (Proteins, Gene)

1/2019	Klotho protein supplementation reduces blood pressure and renal hypertrophy in db/db mice, a model of type 2 diabetes.
2/2017	Podocyte-specific NF-κB inhibition ameliorates proteinuria in adriamycin-induced nephropathy in mice.
9/2014	Kruppel-like factor 4 protein regulates isoproterenol-induced cardiac hypertrophy by modulating myocardin expression and activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maho Yamashita Research Topics

Disease

3	Chronic Renal Insufficiency 11/2017 - 01/2013
3	Vascular System Injuries 09/2014 - 05/2013
2	Fibrosis (Cirrhosis) 03/2023 - 11/2022
2	Inflammation (Inflammations) 03/2023 - 01/2023
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2023 - 01/2021
2	Type 2 Diabetes Mellitus (MODY) 01/2019 - 01/2013
1	Non-alcoholic Fatty Liver Disease 10/2023
1	Hepatic Encephalopathy 03/2023
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2022
1	Infections 10/2022
1	Communicable Diseases (Infectious Diseases) 10/2022
1	Renal Tubular Acidosis (Distal Renal Tubular Acidosis) 12/2021
1	Oral Ulcer (Mouth Ulcer) 08/2021
1	Alopecia (Baldness) 08/2021
1	Autoimmune Hepatitis 08/2021
1	Body Weight (Weight, Body) 01/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Necrosis 01/2019
1	Hypertrophy 01/2019
1	Albuminuria 01/2019
1	Proteinuria 02/2017
1	Reperfusion Injury 01/2016
1	Autosomal Recessive Polycystic Kidney (Polycystic Kidney Disease, Infantile, Type I) 11/2015
1	Acute Kidney Injury (Acute Renal Failure) 01/2015
1	Vascular Diseases (Vascular Disease) 09/2014
1	Cardiomegaly (Heart Hypertrophy) 09/2014
1	Atherosclerosis 09/2014
1	Vascular Calcification 01/2013
1	Hyperglycemia 01/2013

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2023 - 01/2016
2	AlbuminsIBA 03/2023 - 02/2017
2	Phosphates (Orthophosphate)IBA 11/2017 - 01/2013
2	CreatinineIBA 02/2017 - 01/2016
2	myocardinIBA 09/2014 - 05/2013
2	Differentiation AntigensIBA 05/2013 - 01/2013
1	Rifaximin (L 105)FDA Link 03/2023
1	C-Reactive ProteinIBA 03/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2023
1	AmmoniaIBA 03/2023
1	CytokinesIBA 01/2023
1	ChemokinesIBA 01/2023
1	AutoantigensIBA 01/2023
1	Bile Acids and Salts (Bile Acids)IBA 01/2023
1	aspartic acid glycine arginineIBA 11/2022
1	IntegrinsIBA 11/2022
1	LipopolysaccharidesIBA 10/2022
1	Carbapenems (Carbapenem Antibiotics)IBA 10/2022
1	Colistin (Coly-Mycin)FDA Link 10/2022
1	NucleotidesIBA 12/2021
1	Azathioprine (Imuran)FDA LinkGeneric 08/2021
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2021
1	Fibronectins (Fibronectin)IBA 01/2019
1	nephrinIBA 02/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2017
1	NitrogenIBA 01/2016
1	Urea (Carbamide)FDA LinkGeneric 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 11/2015
1	HydrogenIBA 01/2015
1	AntioxidantsIBA 01/2015
1	olmesartanIBA 09/2014
1	Atrial Natriuretic Factor (ANF)IBA 09/2014
1	Angiotensin IIIBA 09/2014
1	Kruppel-Like Factor 4IBA 09/2014
1	Histone Deacetylase InhibitorsIBA 09/2014
1	N-propionylprocainamideIBA 09/2014
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 09/2014
1	trichostatin A (A 300)IBA 09/2014
1	Tamoxifen FDA LinkGeneric 01/2014
1	Glucose (Dextrose)FDA LinkGeneric 01/2013

Therapy/Procedure

1	Intravenous Administration 02/2017